A detailed history of Citigroup Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Citigroup Inc holds 936,412 shares of TEVA stock, worth $16.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
936,412
Previous 3,617,747 74.12%
Holding current value
$16.4 Million
Previous $51 Million 70.19%
% of portfolio
0.01%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$12.78 - $17.4 $34.3 Million - $46.7 Million
-2,681,335 Reduced 74.12%
936,412 $15.2 Million
Q1 2024

May 10, 2024

BUY
$10.67 - $14.43 $34.6 Million - $46.9 Million
3,247,067 Added 875.98%
3,617,747 $51 Million
Q4 2023

Feb 09, 2024

SELL
$8.12 - $10.63 $290,728 - $380,596
-35,804 Reduced 8.81%
370,680 $3.87 Million
Q3 2023

Nov 09, 2023

SELL
$7.48 - $10.7 $2.46 Million - $3.51 Million
-328,347 Reduced 44.68%
406,484 $4.15 Million
Q2 2023

Aug 10, 2023

SELL
$7.2 - $9.47 $29.2 Million - $38.5 Million
-4,060,549 Reduced 84.68%
734,831 $5.53 Million
Q1 2023

May 11, 2023

BUY
$8.36 - $11.37 $33.8 Million - $46 Million
4,043,784 Added 538.03%
4,795,380 $42.4 Million
Q4 2022

Feb 09, 2023

SELL
$7.95 - $9.48 $3.64 Million - $4.34 Million
-458,241 Reduced 37.88%
751,596 $6.85 Million
Q3 2022

Nov 10, 2022

SELL
$6.86 - $11.95 $23.8 Million - $41.4 Million
-3,468,047 Reduced 74.14%
1,209,837 $9.76 Million
Q2 2022

Aug 10, 2022

BUY
$7.38 - $10.4 $32,457 - $45,739
4,398 Added 0.09%
4,677,884 $35.2 Million
Q1 2022

May 12, 2022

SELL
$7.33 - $9.39 $7.57 Million - $9.7 Million
-1,032,819 Reduced 18.1%
4,673,486 $43.9 Million
Q4 2021

Feb 10, 2022

BUY
$7.9 - $10.19 $28.6 Million - $36.9 Million
3,620,439 Added 173.57%
5,706,305 $45.7 Million
Q3 2021

Nov 10, 2021

BUY
$8.38 - $10.18 $17.5 Million - $21.2 Million
2,085,866 New
2,085,866 $20.3 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.